Altamira Therapeutics Ltd. Liabilities
Altamira Therapeutics Ltd. (CYTOF) had Liabilities of $3.06 million as of 2025-06-30, per its 6-K filed 2025-08-29.
Financial Statements › Notes
ifrs-full:Liabilities · last filed 2025-08-29
- 2023-12-31: Liabilities 1.24M CHF.
- 2023-06-30: Liabilities 8.03M CHF.
- 2022-12-31: Liabilities 14.62M CHF.
- 2022-06-30: Liabilities 11.74M CHF; Liabilities as first filed 10.80M CHF.
CHF
| Period end | Liabilities | Liabilities as first filed |
|---|---|---|
| 2023-12-31 | 1.24M CHF 20-F/A · filed 2024-04-22 | |
| 2023-06-30 | 8.03M CHF 6-K · filed 2023-09-12 | |
| 2022-12-31 | 14.62M CHF 20-F/A · filed 2024-04-22 | |
| 2022-06-30 | 11.74M CHF 6-K/A · filed 2023-08-21 | 10.80M CHF 6-K · filed 2022-11-30 |
| 2021-12-31 | 6.13M CHF 6-K/A · filed 2023-08-21 | |
| 2021-06-30 | 3.65M CHF 6-K · filed 2021-09-08 | |
| 2020-12-31 | 4.03M CHF 20-F · filed 2022-04-12 | |
| 2020-06-30 | 3.49M CHF 6-K/A · filed 2020-09-17 | |
| 2019-12-31 | 3.19M CHF 20-F · filed 2021-03-31 | |
| 2019-06-30 | 2.78M CHF 6-K · filed 2019-08-15 | |
| 2018-12-31 | 6.23M CHF 20-F · filed 2020-04-16 | |
| 2017-12-31 | 19.99M CHF 20-F · filed 2019-03-14 | |
| 2016-12-31 | 21.52M CHF 20-F · filed 2018-03-22 |
USD
| Period end | Liabilities |
|---|---|
| 2025-06-30 | $3.06M 6-K · filed 2025-08-29 |
| 2024-12-31 | $2.09M 6-K · filed 2025-08-29 |
| 2024-06-30 | $1.75M 6-K · filed 2024-09-24 |
| 2023-12-31 | $1.47M 20-F · filed 2025-04-30 |
| 2023-01-01 | $15.80M 20-F · filed 2025-04-30 |